Entana, Roxan .

HRN: 25-05-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2024
CEFTRIAXONE 1G (VIAL)
08/02/2024
08/09/2024
IV
2gm
OD
Colonic Mass, Gut Obstruction
Waiting Final Action 
08/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/02/2024
08/09/2024
IV
500mg
Q8
Colonic Mass; Gut Obstruction
Waiting Final Action 
08/20/2024
CEFIXIME 200MG (CAP)
08/20/2024
08/26/2024
PO
200mg
Bid
S/P Ileostomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: